Agnieszka Boesen

Array ( [id] => 7307467 [patent_doc_number] => 20040141980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Recombinant antibodies against infectious bursal disease virus (ibdv)' [patent_app_type] => new [patent_app_number] => 10/479670 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 21930 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20040141980.pdf [firstpage_image] =>[orig_patent_app_number] => 10479670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7103423 [patent_doc_number] => 20050106149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Antibodies abolish prion propagation and remote clearance of infectivity' [patent_app_type] => utility [patent_app_number] => 10/475558 [patent_app_country] => US [patent_app_date] => 2002-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9154 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106149.pdf [firstpage_image] =>[orig_patent_app_number] => 10475558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7261451 [patent_doc_number] => 20040241177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Novel compositions and uses therefor' [patent_app_type] => new [patent_app_number] => 10/475203 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 26349 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241177.pdf [firstpage_image] =>[orig_patent_app_number] => 10475203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046900 [patent_doc_number] => 20020168377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Prion protein dimers useful for vaccination' [patent_app_type] => new [patent_app_number] => 10/115984 [patent_app_country] => US [patent_app_date] => 2002-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4826 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20020168377.pdf [firstpage_image] =>[orig_patent_app_number] => 10115984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8232960 [patent_doc_number] => 08198400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Vaccine for modulating between T1 and T2 immune responses' [patent_app_type] => utility [patent_app_number] => 10/106876 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8687 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198400.pdf [firstpage_image] =>[orig_patent_app_number] => 10106876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7328041 [patent_doc_number] => 20040253579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Epstein-barr virus-negative nk cell line' [patent_app_type] => new [patent_app_number] => 10/486484 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7780 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253579.pdf [firstpage_image] =>[orig_patent_app_number] => 10486484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6047514 [patent_doc_number] => 20020168629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Ligand capture-directed selection of antibody' [patent_app_type] => new [patent_app_number] => 10/079802 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16513 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20020168629.pdf [firstpage_image] =>[orig_patent_app_number] => 10079802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8920488 [patent_doc_number] => 08486419 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Attenuated live vaccine' [patent_app_type] => utility [patent_app_number] => 10/450649 [patent_app_country] => US [patent_app_date] => 2002-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6675 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10450649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7323445 [patent_doc_number] => 20040137421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Method of screening prion disease infection factor' [patent_app_type] => new [patent_app_number] => 10/470848 [patent_app_country] => US [patent_app_date] => 2003-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12326 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137421.pdf [firstpage_image] =>[orig_patent_app_number] => 10470848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7208808 [patent_doc_number] => 20050053620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Recombinant vaccinia virus vaccine' [patent_app_type] => utility [patent_app_number] => 10/495974 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7404 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053620.pdf [firstpage_image] =>[orig_patent_app_number] => 10495974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32499 [patent_doc_number] => 07785586 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-31 [patent_title] => 'Monoclonal antibodies directed against hepatitis B viruses' [patent_app_type] => utility [patent_app_number] => 10/399668 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9216 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/785/07785586.pdf [firstpage_image] =>[orig_patent_app_number] => 10399668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095291 [patent_doc_number] => 20020051794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Novel parenteral vaccine formulations and uses thereof' [patent_app_type] => new [patent_app_number] => 09/925635 [patent_app_country] => US [patent_app_date] => 2001-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9092 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 51 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20020051794.pdf [firstpage_image] =>[orig_patent_app_number] => 09925635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856081 [patent_doc_number] => 20030129582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Method for determining early HCV seroconversion' [patent_app_type] => new [patent_app_number] => 09/896032 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5087 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129582.pdf [firstpage_image] =>[orig_patent_app_number] => 09896032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4554747 [patent_doc_number] => 07820786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-26 [patent_title] => 'Synthetic peptides and uses therefore' [patent_app_type] => utility [patent_app_number] => 10/296734 [patent_app_country] => US [patent_app_date] => 2001-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 217 [patent_figures_cnt] => 34 [patent_no_of_words] => 40966 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820786.pdf [firstpage_image] =>[orig_patent_app_number] => 10296734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846310 [patent_doc_number] => 20030165477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Poxvirus with targeted infection specificity' [patent_app_type] => new [patent_app_number] => 09/832899 [patent_app_country] => US [patent_app_date] => 2001-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17566 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165477.pdf [firstpage_image] =>[orig_patent_app_number] => 09832899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7349409 [patent_doc_number] => 20040047879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof' [patent_app_type] => new [patent_app_number] => 10/344502 [patent_app_country] => US [patent_app_date] => 2003-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5609 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20040047879.pdf [firstpage_image] =>[orig_patent_app_number] => 10344502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 376822 [patent_doc_number] => 07311920 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-12-25 [patent_title] => 'Virus coat protein/receptor chimeras and methods of use' [patent_app_type] => utility [patent_app_number] => 09/684026 [patent_app_country] => US [patent_app_date] => 2000-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19924 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/311/07311920.pdf [firstpage_image] =>[orig_patent_app_number] => 09684026 [rel_patent_id] =>[rel_patent_doc_number] =>)